Position in LQDA
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$277,221
-$55,538 QoQ
Shares Held
3,477
-64.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#244
of 333 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAPSTONE INVESTMENT ADVISORS, LLC holds $5,128,141 across 6 Drug Manufacturers - Specialty & Generic names. LQDA ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
35,180 | $2,528,034 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
11,150 | $922,997 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,123 | $608,475 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
13,568 | $470,402 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
6,902 | $321,012 | |
| 6 | LQDA |
Liquidia Corp
This page
|
3,477 | $277,221 |
All Filings in LQDA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,221 | 3,477 | Shares | Defined | 2026-08-17 | |
| 2025-12-31 | $332,759 | 9,648 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||